{"name":"Ortho Biotech Products, L.P.","slug":"ortho-biotech-products-l-p","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Epoetin alfa and Darbepoetin alfa","genericName":"Epoetin alfa and Darbepoetin alfa","slug":"epoetin-alfa-and-darbepoetin-alfa","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Epoetin alfa and Darbepoetin alfa","genericName":"Epoetin alfa and Darbepoetin alfa","slug":"epoetin-alfa-and-darbepoetin-alfa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNdGZ3U3RNcFRfY0toTFJpaWc5VmtwM090WTFlQW03cUJlWjY1WkhSN2pVemZLOUU0T0htZENDV0NFczVXaURPaENubUkwUVhxcE5nSG4wTnotMUFTSkl6cTJPZ0pVbXJnRDVmSnJJcW1qVnhnVkFlV29vRFRGRkYwYXJtY3Jsd25aejd0bGQzNW1sYWR3Q25IREgtaUFmN19wREZUZHMtTC1OWTdVVFdmWQ?oc=5","date":"2025-03-29","type":"pipeline","source":"Bloomberg Law News","summary":"Janssen Liability Increased to $1.6 Billion in Drug Fraud Suit - Bloomberg Law News","headline":"Janssen Liability Increased to $1.6 Billion in Drug Fraud Suit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPWFAtQ0pVV1h2d3VsZkpCRFhNT2dFMkZ3VktlYklBTnVMb3R2UzNFZ3M3cFpVbk9QWlRBa2QweDhmRXc0a0d1NWVkSGVCMV9Kb1FLSTVKQ2xGc3pwQkZzeTB5c1VUY2RRSGRYLTA4blBHQVMweEJNT0I4Tm9BazVNRFJKRVRxc09pOVJWSlpB0gGTAUFVX3lxTE9CRTVnQnF1QmlQbENNbGxFYTN3YXduTTJ0UWhORHRJdjd4V2ZfdUlQN3psS3NBREVObzI1d1EyemRlYlA2ckRkV3I2bmRGeGVndmIzdDE1T0lYOXEzNXc2LVJGQm5QS1MwbFdnQVBtM3VOMmdmSG5RdzdFVGgwR2loT2l0TmpPd0NJT0tXcTJyYUQ1VQ?oc=5","date":"2025-03-28","type":"pipeline","source":"CNBC","summary":"Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - CNBC","headline":"Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE5PN3FMdjFuYVJjODNVeVJTZnRBTjVsNm5SUndCSnhDQ0NkSTlSeUZoMk9aa3RBdWpKUDNiRDE0THYtZDZtNHpRdFljNkFTNTlxUll3UTBZbFlmdlFmRzZNSDFHcVBuWkVlT2oxbVJEcldNUEozWlNVRzlEeXg1elk?oc=5","date":"2022-01-12","type":"pipeline","source":"Pharma Voice","summary":"A Constellation of Talent - Pharma Voice","headline":"A Constellation of Talent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOdVdnVUREU1B1angzRjJHV0lEb2RkeEhDUTlFaHdmcTFZelNILUpWcXB1amw5YjFVTHd0V1hYNXZMbWlfTXljZkVvUzI4QW1NZExzVkhXcl9TNmNrTHlNcGFpNC1pM0kwRUZ6d2F0TURGMi1idUVrTGRwVFVqZUt6b0hEdmJKeE1OS2JUbTVxOFdXTE96d0hxeUZlYzAweFpCN2hSVlNFb3FjS2JLSG42Q3ZVdWNfXzJSNnl5bQ?oc=5","date":"2021-01-20","type":"pipeline","source":"BioSpace","summary":"Dr. Richard Woodman Appointed Chief Clinical Officer of the Oncology Business Group at Eisai Inc. - BioSpace","headline":"Dr. Richard Woodman Appointed Chief Clinical Officer of the Oncology Business Group at Eisai Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPWW9mNXlXTFRmMTdfc1U4dTR5M0JXaFhqUnYxNkg1TXRScTNJLWM5MkQyQ0tiY1J4OUhCTXh4TkNkYU03ZENSamZjWWVLemFVWVNJV1ZiVFFOWnJPTnMtOFg3TGFUa2h1b1RMaXh0Qm1MdF9MekJUSjFyVEZyNTF0T1lB?oc=5","date":"2017-09-08","type":"pipeline","source":"China Daily - Global Edition","summary":"Serving in the name of progress - China Daily - Global Edition","headline":"Serving in the name of progress - China Daily","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}